MAZE Therapeutics Inc
- Stock Issuer and Owners
| MAZE Therapeutics Inc |
| Ticker | MAZE |
| CIK # | 0001842295 |
| CUSIP | 578784100 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 171 Oyster Point Boulevard, Suite 300, South San Francisco, CA 94080 |
| Source |
[EDGAR]
|
| Form 3/4/5 Filer |
2011 - 2025 |
|
Exter Neil
|
|
|
Maze Therapeutics, Inc.
|
|
|
Third Rock Ventures IV, L.P.
|
|
|
Third Rock Ventures GP IV, L.P.
|
|
|
Third Rock Ventures V, L.P.
|
|
|
TRV GP V LLC
|
|
|
TRV GP IV LLC
|
|
|
Third Rock Ventures GP V, LP
|
|
|
Homcy Charles J
|
|
|
Lim Jonathan E
|
|
|
Bernstein Harold
|
|
|
Courtney Phillips
|
|
|
Andrews Nancy C
|
|
|
Brush James
|
|
|
Colowick Alan
|
|
|
Kathiresan Sekar
|
|
|
Scheller Richard H
|
|
|
Sohn Catherine A.
|
|
|
Spiegelman Daniel K
|
|
|
Tong Jeffrey K
|
|
|
ARCH Venture Fund X, L.P.
|
|
|
ARCH Venture Fund X Overage, L.P.
|
|
|
ARCH Venture Partners X, LLC
|
|
|
Crandell Keith
|
|
|
Gillis Steven
|
|
|
ARCH Venture Partners X, L.P.
|
|
|
ARCH Venture Partners X Overage, L.P.
|
|
|
Nelsen Robert
|
|
|
Burow Kristina
|
|
|
Coloma Jason V
|
|
|
Dandekar Atul
|
|
|
Bachrodt Amy
|
|
| Form 13F Holdings |
| Firm |
Period |
DFND |
Voting |
Shares |
| TRV GP IV LLC |
[2025-06-30]
|
SOLE |
6,073,958 |
6,073,958 |
| Frazier Life Sciences Management LP |
[2025-06-30]
|
SOLE |
4,567,275 |
4,567,275 |
| Arch Venture Management LLC |
[2025-06-30]
|
SOLE |
0 |
4,120,053 |
| Deep Track Capital LP |
[2025-06-30]
|
SOLE |
3,948,910 |
3,948,910 |
| Matrix Capital Management Company LP |
[2025-06-30]
|
SOLE |
2,486,184 |
2,486,184 |
| Alphabet Inc. |
[2025-06-30]
|
DFND |
0 |
2,412,471 |
| Foresite Capital Management IV, LLC |
[2025-06-30]
|
SOLE |
2,111,919 |
2,111,919 |
| Ah Capital Management LLC |
[2025-06-30]
|
SOLE |
1,702,225 |
1,702,225 |
| Janus Henderson Group PLC |
[2025-06-30]
|
DFND |
0 |
1,401,260 |
| General Catalyst Group Management LLC |
[2025-06-30]
|
DFND |
1,035,910 |
1,035,910 |
| TRV GP V LLC |
[2025-06-30]
|
SOLE |
950,800 |
950,800 |
| Woodline Partners LP |
[2025-06-30]
|
SOLE |
940,700 |
940,700 |
| Casdin Capital LLC |
[2025-06-30]
|
SOLE |
758,857 |
758,857 |
| Harvard Management Co Inc |
[2025-06-30]
|
SOLE |
637,528 |
637,528 |
| BlackRock, Inc. |
[2025-06-30]
|
SOLE |
601,539 |
614,704 |
| Logos Global Management LP |
[2025-06-30]
|
SOLE |
611,914 |
611,914 |
| FMR LLC |
[2025-06-30]
|
DFND |
553,897 |
554,534 |
| HHLR Advisors Ltd |
[2025-06-30]
|
OTR |
0 |
457,535 |
| Vanguard Group Inc |
[2025-06-30]
|
SOLE |
0 |
412,014 |
| Sphera Funds Management Ltd |
[2025-06-30]
|
DFND |
356,453 |
356,453 |
| Foresite Capital Management V, LLC |
[2025-06-30]
|
SOLE |
345,191 |
345,191 |
| Ikarian Capital LLC |
[2025-06-30]
|
SOLE |
262,740 |
262,740 |
| Geode Capital Management LLC |
[2025-06-30]
|
DFND |
231,237 |
231,237 |
| Driehaus Capital Management LLC |
[2025-06-30]
|
SOLE |
193,400 |
193,400 |
| Octagon Capital Advisors LP |
[2025-06-30]
|
SOLE |
177,667 |
177,667 |
| State Street Corp |
[2025-06-30]
|
DFND |
132,863 |
144,685 |
| Alyeska Investment Group LP |
[2025-06-30]
|
SOLE |
125,000 |
125,000 |
| Northern Trust Corp |
[2025-06-30]
|
DFND |
84,260 |
84,260 |
| Boothbay Fund Management LLC |
[2025-06-30]
|
OTR |
0 |
75,530 |
| Charles Schwab Investment Management Inc |
[2025-06-30]
|
SOLE |
75,171 |
75,171 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 161543758, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
234419506